Operator

Ladies and gentlemen, thank you for standing by for So-Young's First Quarter 2026 Earnings Conference Call.

[Operator Instructions]

As a reminder, today's conference call is being recorded. I would now like to turn the meeting over to your host for today's call, Ms. Mona Qiao. Please proceed, Mona.

Mona Qiao
Investor Relation Officer

Thank you, operator, and thank you, everyone, for joining So-Young's First Quarter 2026 Earnings Conference Call. Joining me today on the call is Mr. Xing Jin, Founder, Chairman and CEO; and Ms. Zhang Sha, VP of Finance.

Before we begin, please refer to the safe harbor statement in our earnings release, which applies today's call as we will be making forward-looking statements.

Please also note that we will discuss non-GAAP measures today, which are more thoroughly explained and reconciled to the most comparable measures reported under GAAP in our earnings release on our Investor Relations website and filings with SEC. Please also note, all figures mentioned in this call are in RMB.

And this time, I'd like to turn the call over to Mr. Xing Jin.

Xing Jin
Co-Founder, CEO, Interim CFO & Chairman

[Foreign Language]

Mona Qiao
Investor Relation Officer

[Interpreted] Hello, everyone, and welcome to today's earnings call.

Xing Jin
Co-Founder, CEO, Interim CFO & Chairman

[Foreign Language]

Mona Qiao
Investor Relation Officer

[Interpreted] Entering 2026, China's medical aesthetic industry continues to evolve with demand becoming more routine and supply continue to grow. Large-scale operational capabilities and a uniform delivery framework have become the key mode